These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25257948)

  • 1. An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.
    Fukunaga T; Zou W; Rohatgi N; Colca JR; Teitelbaum SL
    J Bone Miner Res; 2015 Mar; 30(3):481-8. PubMed ID: 25257948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.
    Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN
    J Biol Chem; 2012 Jul; 287(28):23537-48. PubMed ID: 22621923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of selective PPARγ modulators in the differentiation of osteoclasts.
    Wu H; Li L; Ma Y; Chen Y; Zhao J; Lu Y; Shen P
    J Cell Biochem; 2013 Sep; 114(9):1969-77. PubMed ID: 23494891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of rosiglitazone on osteoblastic differentiation, osteoclast formation and bone resorption.
    Cho ES; Kim MK; Son YO; Lee KS; Park SM; Lee JC
    Mol Cells; 2012 Feb; 33(2):173-81. PubMed ID: 22286232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
    Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
    Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.
    Li Y; Wang Z; Furukawa N; Escaron P; Weiszmann J; Lee G; Lindstrom M; Liu J; Liu X; Xu H; Plotnikova O; Prasad V; Walker N; Learned RM; Chen JL
    J Biol Chem; 2008 Apr; 283(14):9168-76. PubMed ID: 18263587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss.
    Hou Y; Cao X; Hu X; Li X; Shi X; Wang H; Peng C; Li J; Li J; Li Q; Wu C; Xiao X
    Genes Dis; 2018 Sep; 5(3):290-299. PubMed ID: 30320193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones.
    Benova A; Ferencakova M; Bardova K; Funda J; Prochazka J; Spoutil F; Cajka T; Dzubanova M; Balcaen T; Kerckhofs G; Willekens W; van Lenthe GH; Alquicer G; Pecinova A; Mracek T; Horakova O; Rossmeisl M; Kopecky J; Tencerova M
    Mol Metab; 2022 Nov; 65():101598. PubMed ID: 36103974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.
    Lazarenko OP; Rzonca SO; Hogue WR; Swain FL; Suva LJ; Lecka-Czernik B
    Endocrinology; 2007 Jun; 148(6):2669-80. PubMed ID: 17332064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMHX008, a novel peroxisome proliferator-activated receptor γ partial agonist, enhances insulin sensitivity in vitro and in vivo.
    Ming Y; Hu X; Song Y; Liu Z; Li J; Gao R; Zhang Y; Mei H; Guo T; Xiao L; Wang B; Wu C; Xiao X
    PLoS One; 2014; 9(7):e102102. PubMed ID: 25004107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of PPARγ for the osteoblastic differentiation.
    Viccica G; Francucci CM; Marcocci C
    J Endocrinol Invest; 2010; 33(7 Suppl):9-12. PubMed ID: 20938219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGC1beta mediates PPARgamma activation of osteoclastogenesis and rosiglitazone-induced bone loss.
    Wei W; Wang X; Yang M; Smith LC; Dechow PC; Sonoda J; Evans RM; Wan Y
    Cell Metab; 2010 Jun; 11(6):503-16. PubMed ID: 20519122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo.
    Bhalla K; Hwang BJ; Choi JH; Dewi R; Ou L; Mclenithan J; Twaddel W; Pozharski E; Stock J; Girnun GD
    J Biol Chem; 2011 Dec; 286(48):41626-41635. PubMed ID: 21979952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal consequences of thiazolidinedione therapy.
    Grey A
    Osteoporos Int; 2008 Feb; 19(2):129-37. PubMed ID: 17901911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81).
    Jeninga EH; Bugge A; Nielsen R; Kersten S; Hamers N; Dani C; Wabitsch M; Berger R; Stunnenberg HG; Mandrup S; Kalkhoven E
    J Biol Chem; 2009 Sep; 284(39):26385-93. PubMed ID: 19633298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.
    Wang QA; Zhang F; Jiang L; Ye R; An Y; Shao M; Tao C; Gupta RK; Scherer PE
    Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29483301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo.
    Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ
    Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.
    Schopfer FJ; Cole MP; Groeger AL; Chen CS; Khoo NK; Woodcock SR; Golin-Bisello F; Motanya UN; Li Y; Zhang J; Garcia-Barrio MT; Rudolph TK; Rudolph V; Bonacci G; Baker PR; Xu HE; Batthyany CI; Chen YE; Hallis TM; Freeman BA
    J Biol Chem; 2010 Apr; 285(16):12321-33. PubMed ID: 20097754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.